[Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
To assess effectiveness of ACE inhibitor quinapril in patients with moderate cardiac failure of ischemic etiology. 20 patients received quinapril in a daily dose 20 mg for 6 months. Clinical condition, exercise tolerance, functional and geometric parameters of the left ventricle, Holter monitoring, heart rhythm variability, late potentials were studied before and after the treatment. The treatment relieved symptoms significantly, exercise tolerance increased, positive changes occurred in systotic, diastotic functions and left ventricular geometry. Ischemic episodes, supraventricular extrasystoles reduced in number and duration. Quinapril is an effective drug for treatment of moderate ischemic heart failure.